With its current market cap of just 4.6M RXMD is 2
Post# of 1525
Market cap of a company in this sector (Drugs/Pharmaceutical) easily reaches 4x the P/S ratio...so for 22M revs in 2017 the RXMD pps fair market value, not even taking its constant market expansion into account, should be around 26+ cents.
http://pages.stern.nyu.edu/~adamodar/New_Home...sdata.html